RUMORED BUZZ ON ABBV-744 FOR SMALL CELL LUNG CANCER RESEARCH

In Segment A, contributors will get various doses and schedules of oral ABBV-744 tablet to identify safe dosing regimen. Additional contributors will likely be enrolled at the discovered monotherapy dosign routine. In Segment B, contributors will acquire oral ruxolitinib and ABBV-744 are going to be specified as "insert-on" therapy. In Segment C, c